Application of chromosomal microarray analysis in the prenatal diagnosis of fetuses with isolated Congenital anomalies of the kidney and urinary tract.
10.3760/cma.j.cn511374-20250707-00410
- Author:
Xiaoyu DU
1
,
2
;
Yan MIAO
;
Jiashan LI
;
Siying LIANG
;
Wei ZHAO
;
Yingchao ZHOU
;
Nan JIANG
Author Information
1. Center of Genetic Testing, Qingdao Women and Children's Hospital, Qingdao, Shandong 266034, China. sdqd_jn@
2. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Female;
Pregnancy;
Prenatal Diagnosis/methods*;
DNA Copy Number Variations/genetics*;
Kidney/abnormalities*;
Adult;
Ultrasonography, Prenatal;
Urogenital Abnormalities/diagnosis*;
Microarray Analysis/methods*;
Retrospective Studies;
Urinary Tract/abnormalities*;
Fetus;
Pregnancy Outcome;
Vesico-Ureteral Reflux
- From:
Chinese Journal of Medical Genetics
2025;42(9):1033-1038
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the detection rate of copy number variations (CNVs) in fetuses with isolated Congenital anomalies of the kidney and urinary tract (CAKUT) and pregnancy outcomes in order to provide a basis for genetic counseling.
METHODS:One hundred and eighty eight fetuses who underwent chromosomal microarray analysis (CMA) due to isolated CAKUT detected by prenatal ultrasonography at Qingdao Women and Children's Hospital from January 2021 to December 2024 were selected as the study subjects. According to the ultrasound findings, the fetuses were divided into 8 groups, including renal parenchymal dysplasia group, renal cystic dysplasia group, simple renal parenchymal echo enhancement group, abnormal development of renal collecting system group, duplicated kidney group, ectopic kidney group, horseshoe kidney group, and bladder/posterior urethral abnormalities group. The detection of CNVs was retrospectively analyzed, and the pregnant women were followed up to summarize their pregnancy outcomes. 2 test (or Fisher's exact probability method) was used to compare the CNV detection rates between the groups. This study was approved by the Medical Ethics Committee of the Qingdao Women and Children's Hospital (Ethics No.: QFELL-YJ-2025-85).
RESULTS:Among the 188 fetuses with isolated CAKUT, 23 CNVs (12.23%) were detected, of which 13 cases (6.91%) were pathogenic and 10 cases were rated as variants of unknown significance (VOUS). Among the 8 groups, the three groups with the highest proportion were renal cystic dysplasia group, renal metaplasia group, and renal parenchymal dysplasia group. The detection rates of pathogenic CNVs in the three groups were 1.79% (1/56), 6.78% (4/59), and 16.67% (5/30), respectively, with statistically significant differences (P < 0.05). Parental verification was conducted on 12 fetuses detected with the CNVs, confirming that 2 cases were de novo and 10 were inherited from parents with a normal phenotype. After genetic counseling, the parents of 9 fetuses opted to terminate the pregnancy, while 11 chose to continue with the pregnancy, and 3 were lost to follow-up. At the time of last follow-up, the youngest offspring was 5 months old and the oldest was 3 years and 11 months old. One child had renal aplasia, and two were born with hydronephrosis, which have been cured through surgery. The remainders had no obvious abnormality with their growth and development.
CONCLUSION:CMA testing has important value for prenatal diagnosis of isolated CAKUT. In this study, the detection rate of pathogenic CNVs has increased sequentially in fetuses with renal cystic developmental abnormalities, renal collecting system developmental abnormalities, and renal parenchymal dysplasia, while there was no significant difference in the detection rate of CNVs. For fetuses with isolated CAKUT detected by prenatal ultrasound, CMA testing should be considered, and reasonable pregnancy decisions should be made based on the results of prenatal ultrasound and parental verification.
